Pediatric anthrax clinical management

John S. Bradley, Steven E. Krug, William A. Bower, Amanda C. Cohn, Dana Meaney-Delman, Andrew T. Pavia, Sarita Chung, Daniel B. Fagbuyi, Margaret Fisher, Scott Needle, David J. Schonfeld, John Alexander, Andrew Garrett, Georgina Peacock, Sally Phillips, Erica Radden, David Siegel, Laura Aird, Sean Diederich, Tamar HaroMichael Thomas Brady, Carrie Lynn Byington, H. Dele Davies, Kathryn M. Edwards, Mary Anne Jackson, Yvonne Aida Maldonado, Dennis L Murray, Walter A. Orenstein, Mobeen H. Rathore, Mark H. Sawyer, Gordon E. Schutze, Rodney E. Willoughby, Theoklis Zaoutis, Henry H. Bernstein, David Winston Kimberlin, Sarah S. Long, H. Cody Meissner, Marc Fischer, Bruce Gellin, Richard L. Gorman, Lucia Lee, R. Douglas Pratt, Jennifer S. Read, Joan Robinson, Marco Aurelio Palazzi Safadi, Jane Seward, Geoffrey Simon, Jeffrey Robert Starke, Tina Quanbee Tan, Jennifer Frantz

Research output: Contribution to journalArticle

19 Citations (Scopus)

Abstract

Anthrax is a zoonotic disease caused by Bacillus anthracis, which has multiple routes of infection in humans, manifesting in different initial presentations of disease. Because B anthracis has the potential to be used as a biological weapon and can rapidly progress to systemic anthrax with high mortality in those who are exposed and untreated, clinical guidance that can be quickly implemented must be in place before any intentional release of the agent. This document provides clinical guidance for the prophylaxis and treatment of neonates, infants, children, adolescents, and young adults up to the age of 21 (referred to as "children") in the event of a deliberate B anthracis release and offers guidance in areas where the unique characteristics of children dictate a different clinical recommendation from adults.

Original languageEnglish (US)
Pages (from-to)e1411-e1436
JournalPediatrics
Volume133
Issue number5
DOIs
StatePublished - May 2014

Fingerprint

Anthrax
Pediatrics
Biological Warfare Agents
Bacillus anthracis
Zoonoses
Young Adult
Newborn Infant
Mortality
Infection
Therapeutics

Keywords

  • Anthrax
  • Anthrax vaccine
  • Biological weapon
  • Bioterrorism
  • Children
  • Pediatrics
  • Prophylaxis

ASJC Scopus subject areas

  • Pediatrics, Perinatology, and Child Health

Cite this

Bradley, J. S., Krug, S. E., Bower, W. A., Cohn, A. C., Meaney-Delman, D., Pavia, A. T., ... Frantz, J. (2014). Pediatric anthrax clinical management. Pediatrics, 133(5), e1411-e1436. https://doi.org/10.1542/peds.2014-0563

Pediatric anthrax clinical management. / Bradley, John S.; Krug, Steven E.; Bower, William A.; Cohn, Amanda C.; Meaney-Delman, Dana; Pavia, Andrew T.; Chung, Sarita; Fagbuyi, Daniel B.; Fisher, Margaret; Needle, Scott; Schonfeld, David J.; Alexander, John; Garrett, Andrew; Peacock, Georgina; Phillips, Sally; Radden, Erica; Siegel, David; Aird, Laura; Diederich, Sean; Haro, Tamar; Brady, Michael Thomas; Byington, Carrie Lynn; Davies, H. Dele; Edwards, Kathryn M.; Jackson, Mary Anne; Maldonado, Yvonne Aida; Murray, Dennis L; Orenstein, Walter A.; Rathore, Mobeen H.; Sawyer, Mark H.; Schutze, Gordon E.; Willoughby, Rodney E.; Zaoutis, Theoklis; Bernstein, Henry H.; Kimberlin, David Winston; Long, Sarah S.; Meissner, H. Cody; Fischer, Marc; Gellin, Bruce; Gorman, Richard L.; Lee, Lucia; Pratt, R. Douglas; Read, Jennifer S.; Robinson, Joan; Safadi, Marco Aurelio Palazzi; Seward, Jane; Simon, Geoffrey; Starke, Jeffrey Robert; Tan, Tina Quanbee; Frantz, Jennifer.

In: Pediatrics, Vol. 133, No. 5, 05.2014, p. e1411-e1436.

Research output: Contribution to journalArticle

Bradley, JS, Krug, SE, Bower, WA, Cohn, AC, Meaney-Delman, D, Pavia, AT, Chung, S, Fagbuyi, DB, Fisher, M, Needle, S, Schonfeld, DJ, Alexander, J, Garrett, A, Peacock, G, Phillips, S, Radden, E, Siegel, D, Aird, L, Diederich, S, Haro, T, Brady, MT, Byington, CL, Davies, HD, Edwards, KM, Jackson, MA, Maldonado, YA, Murray, DL, Orenstein, WA, Rathore, MH, Sawyer, MH, Schutze, GE, Willoughby, RE, Zaoutis, T, Bernstein, HH, Kimberlin, DW, Long, SS, Meissner, HC, Fischer, M, Gellin, B, Gorman, RL, Lee, L, Pratt, RD, Read, JS, Robinson, J, Safadi, MAP, Seward, J, Simon, G, Starke, JR, Tan, TQ & Frantz, J 2014, 'Pediatric anthrax clinical management', Pediatrics, vol. 133, no. 5, pp. e1411-e1436. https://doi.org/10.1542/peds.2014-0563
Bradley JS, Krug SE, Bower WA, Cohn AC, Meaney-Delman D, Pavia AT et al. Pediatric anthrax clinical management. Pediatrics. 2014 May;133(5):e1411-e1436. https://doi.org/10.1542/peds.2014-0563
Bradley, John S. ; Krug, Steven E. ; Bower, William A. ; Cohn, Amanda C. ; Meaney-Delman, Dana ; Pavia, Andrew T. ; Chung, Sarita ; Fagbuyi, Daniel B. ; Fisher, Margaret ; Needle, Scott ; Schonfeld, David J. ; Alexander, John ; Garrett, Andrew ; Peacock, Georgina ; Phillips, Sally ; Radden, Erica ; Siegel, David ; Aird, Laura ; Diederich, Sean ; Haro, Tamar ; Brady, Michael Thomas ; Byington, Carrie Lynn ; Davies, H. Dele ; Edwards, Kathryn M. ; Jackson, Mary Anne ; Maldonado, Yvonne Aida ; Murray, Dennis L ; Orenstein, Walter A. ; Rathore, Mobeen H. ; Sawyer, Mark H. ; Schutze, Gordon E. ; Willoughby, Rodney E. ; Zaoutis, Theoklis ; Bernstein, Henry H. ; Kimberlin, David Winston ; Long, Sarah S. ; Meissner, H. Cody ; Fischer, Marc ; Gellin, Bruce ; Gorman, Richard L. ; Lee, Lucia ; Pratt, R. Douglas ; Read, Jennifer S. ; Robinson, Joan ; Safadi, Marco Aurelio Palazzi ; Seward, Jane ; Simon, Geoffrey ; Starke, Jeffrey Robert ; Tan, Tina Quanbee ; Frantz, Jennifer. / Pediatric anthrax clinical management. In: Pediatrics. 2014 ; Vol. 133, No. 5. pp. e1411-e1436.
@article{8bcf4e199c894c50923936ea70262943,
title = "Pediatric anthrax clinical management",
abstract = "Anthrax is a zoonotic disease caused by Bacillus anthracis, which has multiple routes of infection in humans, manifesting in different initial presentations of disease. Because B anthracis has the potential to be used as a biological weapon and can rapidly progress to systemic anthrax with high mortality in those who are exposed and untreated, clinical guidance that can be quickly implemented must be in place before any intentional release of the agent. This document provides clinical guidance for the prophylaxis and treatment of neonates, infants, children, adolescents, and young adults up to the age of 21 (referred to as {"}children{"}) in the event of a deliberate B anthracis release and offers guidance in areas where the unique characteristics of children dictate a different clinical recommendation from adults.",
keywords = "Anthrax, Anthrax vaccine, Biological weapon, Bioterrorism, Children, Pediatrics, Prophylaxis",
author = "Bradley, {John S.} and Krug, {Steven E.} and Bower, {William A.} and Cohn, {Amanda C.} and Dana Meaney-Delman and Pavia, {Andrew T.} and Sarita Chung and Fagbuyi, {Daniel B.} and Margaret Fisher and Scott Needle and Schonfeld, {David J.} and John Alexander and Andrew Garrett and Georgina Peacock and Sally Phillips and Erica Radden and David Siegel and Laura Aird and Sean Diederich and Tamar Haro and Brady, {Michael Thomas} and Byington, {Carrie Lynn} and Davies, {H. Dele} and Edwards, {Kathryn M.} and Jackson, {Mary Anne} and Maldonado, {Yvonne Aida} and Murray, {Dennis L} and Orenstein, {Walter A.} and Rathore, {Mobeen H.} and Sawyer, {Mark H.} and Schutze, {Gordon E.} and Willoughby, {Rodney E.} and Theoklis Zaoutis and Bernstein, {Henry H.} and Kimberlin, {David Winston} and Long, {Sarah S.} and Meissner, {H. Cody} and Marc Fischer and Bruce Gellin and Gorman, {Richard L.} and Lucia Lee and Pratt, {R. Douglas} and Read, {Jennifer S.} and Joan Robinson and Safadi, {Marco Aurelio Palazzi} and Jane Seward and Geoffrey Simon and Starke, {Jeffrey Robert} and Tan, {Tina Quanbee} and Jennifer Frantz",
year = "2014",
month = "5",
doi = "10.1542/peds.2014-0563",
language = "English (US)",
volume = "133",
pages = "e1411--e1436",
journal = "Pediatrics",
issn = "0031-4005",
publisher = "American Academy of Pediatrics",
number = "5",

}

TY - JOUR

T1 - Pediatric anthrax clinical management

AU - Bradley, John S.

AU - Krug, Steven E.

AU - Bower, William A.

AU - Cohn, Amanda C.

AU - Meaney-Delman, Dana

AU - Pavia, Andrew T.

AU - Chung, Sarita

AU - Fagbuyi, Daniel B.

AU - Fisher, Margaret

AU - Needle, Scott

AU - Schonfeld, David J.

AU - Alexander, John

AU - Garrett, Andrew

AU - Peacock, Georgina

AU - Phillips, Sally

AU - Radden, Erica

AU - Siegel, David

AU - Aird, Laura

AU - Diederich, Sean

AU - Haro, Tamar

AU - Brady, Michael Thomas

AU - Byington, Carrie Lynn

AU - Davies, H. Dele

AU - Edwards, Kathryn M.

AU - Jackson, Mary Anne

AU - Maldonado, Yvonne Aida

AU - Murray, Dennis L

AU - Orenstein, Walter A.

AU - Rathore, Mobeen H.

AU - Sawyer, Mark H.

AU - Schutze, Gordon E.

AU - Willoughby, Rodney E.

AU - Zaoutis, Theoklis

AU - Bernstein, Henry H.

AU - Kimberlin, David Winston

AU - Long, Sarah S.

AU - Meissner, H. Cody

AU - Fischer, Marc

AU - Gellin, Bruce

AU - Gorman, Richard L.

AU - Lee, Lucia

AU - Pratt, R. Douglas

AU - Read, Jennifer S.

AU - Robinson, Joan

AU - Safadi, Marco Aurelio Palazzi

AU - Seward, Jane

AU - Simon, Geoffrey

AU - Starke, Jeffrey Robert

AU - Tan, Tina Quanbee

AU - Frantz, Jennifer

PY - 2014/5

Y1 - 2014/5

N2 - Anthrax is a zoonotic disease caused by Bacillus anthracis, which has multiple routes of infection in humans, manifesting in different initial presentations of disease. Because B anthracis has the potential to be used as a biological weapon and can rapidly progress to systemic anthrax with high mortality in those who are exposed and untreated, clinical guidance that can be quickly implemented must be in place before any intentional release of the agent. This document provides clinical guidance for the prophylaxis and treatment of neonates, infants, children, adolescents, and young adults up to the age of 21 (referred to as "children") in the event of a deliberate B anthracis release and offers guidance in areas where the unique characteristics of children dictate a different clinical recommendation from adults.

AB - Anthrax is a zoonotic disease caused by Bacillus anthracis, which has multiple routes of infection in humans, manifesting in different initial presentations of disease. Because B anthracis has the potential to be used as a biological weapon and can rapidly progress to systemic anthrax with high mortality in those who are exposed and untreated, clinical guidance that can be quickly implemented must be in place before any intentional release of the agent. This document provides clinical guidance for the prophylaxis and treatment of neonates, infants, children, adolescents, and young adults up to the age of 21 (referred to as "children") in the event of a deliberate B anthracis release and offers guidance in areas where the unique characteristics of children dictate a different clinical recommendation from adults.

KW - Anthrax

KW - Anthrax vaccine

KW - Biological weapon

KW - Bioterrorism

KW - Children

KW - Pediatrics

KW - Prophylaxis

UR - http://www.scopus.com/inward/record.url?scp=84899892740&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=84899892740&partnerID=8YFLogxK

U2 - 10.1542/peds.2014-0563

DO - 10.1542/peds.2014-0563

M3 - Article

C2 - 24777226

AN - SCOPUS:84899892740

VL - 133

SP - e1411-e1436

JO - Pediatrics

JF - Pediatrics

SN - 0031-4005

IS - 5

ER -